126 related articles for article (PubMed ID: 9815612)
1. Characterization of p16(INK4A) expression in multiple myeloma and plasma cell leukemia.
Urashima M; Teoh G; Ogata A; Chauhan D; Treon SP; Sugimoto Y; Kaihara C; Matsuzaki M; Hoshi Y; DeCaprio JA; Anderson KC
Clin Cancer Res; 1997 Nov; 3(11):2173-9. PubMed ID: 9815612
[TBL] [Abstract][Full Text] [Related]
2. Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma.
Krämer A; Schultheis B; Bergmann J; Willer A; Hegenbart U; Ho AD; Goldschmidt H; Hehlmann R
Leukemia; 2002 Sep; 16(9):1844-51. PubMed ID: 12200702
[TBL] [Abstract][Full Text] [Related]
3. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma.
Roncalli M; Bianchi P; Bruni B; Laghi L; Destro A; Di Gioia S; Gennari L; Tommasini M; Malesci A; Coggi G
Hepatology; 2002 Aug; 36(2):427-32. PubMed ID: 12143052
[TBL] [Abstract][Full Text] [Related]
4. Loss of p16 protein expression associated with methylation of the p16INK4A gene is a frequent finding in Hodgkin's disease.
García JF; Villuendas R; Algara P; Sáez AI; Sánchez-Verde L; Martínez-Montero JC; Martínez P; Piris MA
Lab Invest; 1999 Dec; 79(12):1453-9. PubMed ID: 10616196
[TBL] [Abstract][Full Text] [Related]
5. [Study on structure change and hypermethylation of p16 gene in multiple myeloma].
Fu W; Hou J; Wang D
Zhonghua Xue Ye Xue Za Zhi; 2001 Nov; 22(11):573-6. PubMed ID: 11855144
[TBL] [Abstract][Full Text] [Related]
6. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
Elisei R; Shiohara M; Koeffler HP; Fagin JA
Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
[TBL] [Abstract][Full Text] [Related]
7. p16/INK4a gene inactivation by hypermethylation is associated with aggressive variants of monoclonal gammopathies.
Mateos MV; Garcia-Sanz R; López-Pérez R; Balanzategui A; González MI; Fernández-Calvo J; Moro MJ; Hernández J; Caballero MD; González M; San Miguel JF
Hematol J; 2001; 2(3):146-9. PubMed ID: 11920239
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer.
Kurakawa E; Shimamoto T; Utsumi K; Hirano T; Kato H; Ohyashiki K
Int J Oncol; 2001 Aug; 19(2):277-81. PubMed ID: 11445839
[TBL] [Abstract][Full Text] [Related]
9. Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas.
Nakamura M; Sakaki T; Hashimoto H; Nakase H; Ishida E; Shimada K; Konishi N
Cancer Res; 2001 Sep; 61(17):6335-9. PubMed ID: 11522621
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
[TBL] [Abstract][Full Text] [Related]
11. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
Bearzatto A; Conte D; Frattini M; Zaffaroni N; Andriani F; Balestra D; Tavecchio L; Daidone MG; Sozzi G
Clin Cancer Res; 2002 Dec; 8(12):3782-7. PubMed ID: 12473590
[TBL] [Abstract][Full Text] [Related]
12. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
Sartor M; Steingrimsdottir H; Elamin F; Gäken J; Warnakulasuriya S; Partridge M; Thakker N; Johnson NW; Tavassoli M
Br J Cancer; 1999 Apr; 80(1-2):79-86. PubMed ID: 10389982
[TBL] [Abstract][Full Text] [Related]
13. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
Haviernik P; Schmidt M; Hu X; Wolff L
Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
[TBL] [Abstract][Full Text] [Related]
14. Relationship between expression and methylation status of p16INK4a and the proliferative activity of different areas' tumour cells in human colorectal cancer.
Jie G; Zhixiang S; Lei S; Hesheng L; Xiaojun T
Int J Clin Pract; 2007 Sep; 61(9):1523-9. PubMed ID: 17537196
[TBL] [Abstract][Full Text] [Related]
15. Methylation of the INK4A/ARF locus in blood mononuclear cells.
Deligezer U; Erten N; Akisik EE; Dalay N
Ann Hematol; 2006 Feb; 85(2):102-7. PubMed ID: 16320052
[TBL] [Abstract][Full Text] [Related]
16. p15(INK4b) in bladder carcinomas: decreased expression in superficial tumours.
Le Frère-Belda MA; Cappellen D; Daher A; Gil-Diez-de-Medina S; Besse F; Abbou CC; Thiery JP; Zafrani ES; Chopin DK; Radvanyi F
Br J Cancer; 2001 Nov; 85(10):1515-21. PubMed ID: 11720438
[TBL] [Abstract][Full Text] [Related]
17. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer.
Ishiguro A; Takahata T; Saito M; Yoshiya G; Tamura Y; Sasaki M; Munakata A
J Gastroenterol Hepatol; 2006 Aug; 21(8):1334-9. PubMed ID: 16872319
[TBL] [Abstract][Full Text] [Related]
18. Methylation and expression of p16INK4 tumor suppressor gene in primary colorectal cancer tissues.
Kim BN; Yamamoto H; Ikeda K; Damdinsuren B; Sugita Y; Ngan CY; Fujie Y; Ogawa M; Hata T; Ikeda M; Ohue M; Sekimoto M; Monden T; Matsuura N; Monden M
Int J Oncol; 2005 May; 26(5):1217-26. PubMed ID: 15809712
[TBL] [Abstract][Full Text] [Related]
19. Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer.
Brenner AJ; Paladugu A; Wang H; Olopade OI; Dreyling MH; Aldaz CM
Clin Cancer Res; 1996 Dec; 2(12):1993-8. PubMed ID: 9816158
[TBL] [Abstract][Full Text] [Related]
20. Analysis of promoter hypermethylation of death-associated protein kinase and p16 tumor suppressor genes in actinic keratoses and squamous cell carcinomas of the skin.
Tyler LN; Ai L; Zuo C; Fan CY; Smoller BR
Mod Pathol; 2003 Jul; 16(7):660-4. PubMed ID: 12861061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
